Delivery Order SPE2DB20D2001-SPE2DB22FM35G
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,704.22 for the supply of Pantoprazole Sodium Delayed-Release 40mg tablets. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 9, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,915.62, is a delivery order for the supply of 4,562,055,243 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has a period of performance through September 6, 2023 and uses a Firm Fixed Price pricing type. This award is a standalone order and does not have any set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,515.78 firm fixed-price delivery order is for the supply of 4,564,327,287 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of April 19, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.04 firm fixed-price delivery order is for the supply of 4,567,752,489 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, with a period of performance through April 1, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of 4,564,731,258 units of pantoprazole sodium delayed-release 40 mg tablets in 1,000 count sizes. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,833.54. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQE54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,132.94, is for the delivery of 4,564,451,658 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets 1000s. This is a Firm Fixed Price delivery order contract with a completion date of May 1, 2024. The contract does not have a set-aside designation,...
- This federal contract award is for the delivery of Pantoprazole Sodium DR 40 mg tablets in 1,000 count bottles, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has no set-aside designation, indicating open competition. The total ceiling value of the award is $1,624.18, with a performance period through December 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $24,742.17 firm-fixed price contract has a performance period through February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
- This federal contract award, valued at $1,032.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides Pantoprazole Sodium Delayed-Release 20 mg Tablets in quantities of 90s. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $7,495.89, and has an ultimate completion date of September 12, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide these...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB22FM35GDelivery Order
This federal contract award is for the delivery of 4,555,810 units of Pantoprazole Sodium Delayed-Release tablets (40 mg) to the Defense Logistics Agency (DLA). The $5,981.34 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2021. The contract is a firm-fixed price delivery order with an ultimate completion date of January 3, 2022. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. This contract demonstrates AmerisourceBergen's role as a critical supplier of essential medications and medical commodities to the U.S. Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 12/30/21 |